Wall Street Zen Downgrades Upexi (NASDAQ:UPXI) to Sell

Upexi (NASDAQ:UPXI) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday.

A number of other brokerages have also commented on UPXI. Cantor Fitzgerald dropped their price target on Upexi from $16.00 to $6.00 and set an “overweight” rating for the company in a research note on Friday, November 14th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Upexi in a report on Monday. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, Upexi has an average rating of “Hold” and a consensus target price of $10.50.

Upexi Trading Up 13.7%

Shares of Upexi stock opened at $1.91 on Friday. The company has a market capitalization of $120.73 million, a P/E ratio of -0.45 and a beta of -0.48. The company has a debt-to-equity ratio of 0.68, a quick ratio of 3.39 and a current ratio of 3.41. The company has a fifty day moving average of $2.77 and a 200 day moving average of $4.97. Upexi has a fifty-two week low of $1.67 and a fifty-two week high of $22.57.

Upexi (NASDAQ:UPXI) last issued its earnings results on Wednesday, November 12th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.11). Upexi had a net margin of 264.25% and a negative return on equity of 30.42%. The business had revenue of $9.24 million for the quarter, compared to the consensus estimate of $7.33 million.

Upexi announced that its Board of Directors has authorized a stock buyback program on Thursday, November 13th that authorizes the company to buyback $50.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 25.1% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Insider Activity at Upexi

In related news, Director Gene Salkind purchased 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 20th. The shares were bought at an average price of $2.55 per share, for a total transaction of $127,500.00. Following the acquisition, the director owned 218,750 shares of the company’s stock, valued at approximately $557,812.50. This represents a 29.63% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Allan Marshall purchased 50,000 shares of the stock in a transaction that occurred on Tuesday, December 23rd. The stock was bought at an average price of $1.80 per share, with a total value of $90,000.00. Following the completion of the transaction, the chief executive officer owned 4,046,261 shares of the company’s stock, valued at $7,283,269.80. The trade was a 1.25% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders bought a total of 350,000 shares of company stock valued at $793,000 over the last ninety days. Corporate insiders own 4.42% of the company’s stock.

Institutional Investors Weigh In On Upexi

Several hedge funds and other institutional investors have recently made changes to their positions in UPXI. BlueCrest Capital Management Ltd bought a new stake in shares of Upexi in the 3rd quarter worth about $407,000. Heights Capital Management Inc. bought a new stake in Upexi in the third quarter worth about $1,442,000. Alyeska Investment Group L.P. purchased a new position in shares of Upexi during the third quarter valued at approximately $7,175,000. Nomura Holdings Inc. bought a new position in shares of Upexi during the third quarter valued at approximately $104,000. Finally, Clear Street Group Inc. bought a new position in shares of Upexi during the third quarter valued at approximately $104,000. Hedge funds and other institutional investors own 5.68% of the company’s stock.

Upexi Company Profile

Upexi (NASDAQ: UPXI) is a full-service digital consultancy that partners with brands to design, develop, and deploy digital products and marketing strategies. The company’s expertise spans user experience and interface design, custom software engineering, and data-driven marketing services. By integrating research, creative design, and technical execution, Upexi helps clients accelerate product development cycles and optimize their digital presence.

The firm serves a diverse, global clientele across sectors such as e-commerce, software-as-a-service (SaaS), healthcare, and finance.